BioSpace News Archive

Business

FLX Bio Adds Distinguished Biopharma Industry Leader Michael Giordano, M.D., to Board of Directors

FLX Bio today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.

February 5, 2018

·

3 min read

VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.

The study was established to answer the very practical, logistical questions of how a triage blood test could fit into the current Danish screening program for colorectal cancer.

February 5, 2018

·

5 min read

Invictus Receives $16.5M From Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg

Invictus Medical is pleased to announce that it has received an additional $16,536,234 from the exercise of previously issued warrants and options since December 22, 2017, bringing Invictus’ cash balance to approximately $38M.

February 5, 2018

·

10 min read

Biotech Beach

EBD Group: BIO-Europe Spring(R) Returns to Amsterdam for High-Level Partnering Among Innovative Biotech, Pharma and Investors

The twelfth annual BIO-Europe Spring(R) international partnering conference returns to Amsterdam, The Netherlands, March 12-14, 2018 at the Amsterdam RAI Convention Center.

February 5, 2018

·

3 min read

Health AI Startup Medial EarlySign Predicts Which Diabetic Patients Will Suffer Kidney Damage Within One Year

This represents 25% more patients than would have been identified by commonly used clinical tools and judgement.

February 5, 2018

·

4 min read

Policy

Kowa Pharmaceuticals America, Inc. Announces Agreement with Apotex to Resolve All Outstanding Litigation Related to Livalo (pitavastatin)

Plaintiffs had brought suit against Apotex for patent infringement based on the filing of Apotex’s ANDA seeking Food and Drug Administration (FDA) approval to market 1 mg, 2 mg, and 4 mg pitavastatin calcium tablets, generic to Livalo.

February 5, 2018

·

3 min read

Drug Development

OncBioMune Signs Letter of Intent to Initiate Phase II Trial of ProscaVax for Advanced Prostate Cancer With Urology Clinics of North Texas

Dr. James S. Cochran, M.D., D.A.B.U., F.A.C.S., UCNT Medical Director, has agreed to serve as the trial’s Principal Investigator.

February 5, 2018

·

4 min read

Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement

Relevium is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate secretary on a share for services agreement.

February 5, 2018

·

4 min read

Business

BIOLIFE4D Signs Laboratory Service Agreement With Northwestern University

Agreement provides access to world class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities,.

February 5, 2018

·

3 min read

Metrion Biosciences Awarded £200k Funding Under Innovate UK Biomedical Catalyst Feasibility Award

Metrion Biosciences, the specialist ion channel contract research and drug discovery company, announced today it has been awarded £200k funding under the Innovate UK Biomedical Catalyst Feasibility Award scheme.

February 5, 2018

·

1 min read